ABVC BioPharma Reports $1.28 Million in Q3 Licensing Revenue, Strengthening High-Margin Business Model
ABVC BioPharma has collected $1.28 million in Q3 licensing revenues from multiple partners, including OncoX BioPharma, demonstrating the profitability of its licensing framework with minimal incremental costs.
